Diabetes duration and glycaemic control as predictors of cardiovascular disease and mortality

被引:44
作者
Li, Fu-Rong [1 ]
Yang, Hai-Lian [1 ]
Zhou, Rui [1 ]
Zheng, Jia-Zhen [1 ]
Chen, Guo-Chong [2 ]
Zou, Meng-Chen [3 ]
Wu, Xiao-Xiang [4 ]
Wu, Xian-Bo [1 ]
机构
[1] Southern Med Univ, Sch Publ Hlth, Dept Epidemiol, Guangdong Prov Key Lab Trop Dis Res, Guangzhou 510515, Peoples R China
[2] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA
[3] Southern Med Univ, Nanfang Hosp, Dept Endocrinol & Metab, Guangzhou, Peoples R China
[4] 157th Hosp, Gen Hosp Guangzhou Mil Command, Dept Gen Surg, Guangzhou, Peoples R China
关键词
cardiovascular disease; cohort study; diabetes duration; glycaemic control; prediction;
D O I
10.1111/dom.14348
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims To assess the associations of diabetes duration and glycaemic control (defined by plasma glycated haemoglobin [HbA1c] level) with the risks of cardiovascular disease (CVD) and all-cause mortality and to determine whether the addition of either or both to the established CVD risk factors can improve predictions. Materials and Methods A total of 435 679 participants from the UK Biobank without CVD at baseline were included. Cox models adjusting for classic risk factors (sociodemographic and anthropometric characteristics, lipid profiles and medication use) were used, and predictive utility was determined by the C-index and net reclassification improvement (NRI). Results Compared with participants without diabetes, participants with longer diabetes durations and poorer glycaemic control had a higher risk of fatal/nonfatal CVD. Among participants with diabetes, the fully-adjusted hazard ratios (HRs) for diabetes durations of 5 to <10 years, 10 to <15 years and >= 15 years were 1.15 (95% confidence interval [CI] 0.99, 1.34), 1.50 (95% CI 1.26, 1.79) and 2.22 (95% CI 1.90, 2.58; P-trend <0.01), respectively, compared with participants with diabetes durations <5 years. In addition, those with the longest disease duration (>= 15 years) and poorer glycaemic control (HbA1c >= 64 mmol/mol [8%]) had the highest risk of fatal/nonfatal CVD (HR 3.12, 95% CI 2.52, 3.86). Among participants with diabetes, the addition of both diabetes duration and glycaemic control levels significantly improved both the C-index (change in C-index +0.0254; 95% CI 0.0111, 0.0398) and the overall NRI for fatal/nonfatal CVD (0.0992; 95% CI 0.0085, 0.1755) beyond the use of the classic risk factors. Conclusions Both longer diabetes duration and poorer glycaemic control were associated with elevated risks of CVD and mortality. Clinicians should consider not only glycaemic control but also diabetes duration in CVD risk assessments for participants with diabetes.
引用
收藏
页码:1361 / 1370
页数:10
相关论文
共 46 条
[1]   Effect of type 2 diabetes and its duration on the risk of peripheral arterial disease among men [J].
Al-Delaimy, WK ;
Merchant, AT ;
Rimm, EB ;
Willett, WC ;
Stampfer, MJ ;
Hu, FB .
AMERICAN JOURNAL OF MEDICINE, 2004, 116 (04) :236-240
[2]   Type 2 diabetes in the young: The evolving epidemic - The International Diabetes Federation Consensus Workshop [J].
Alberti, G ;
Zimmet, P ;
Shaw, J ;
Bloomgarden, Z ;
Kaufman, F ;
Silink, M .
DIABETES CARE, 2004, 27 (07) :1798-1811
[3]   Reply 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk [J].
Andrus, Bruce ;
Lacaille, Diane .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (25) :2886-2886
[4]   Duration of Diabetes and Risk of Ischemic Stroke The Northern Manhattan Study [J].
Banerjee, Chirantan ;
Moon, Yeseon P. ;
Paik, Myunghee C. ;
Rundek, Tatjana ;
Mora-McLaughlin, Consuelo ;
Vieira, Julio R. ;
Sacco, Ralph L. ;
Elkind, Mitchell S. V. .
STROKE, 2012, 43 (05) :1212-1217
[5]  
Bradbury KE, 2019, INT J EPIDEMIOL, P1, DOI [10.1093/ije/dyz064, DOI 10.1093/IJE/DYZ064]
[6]  
Collins R, 2012, LANCET, V379, P1173, DOI [10.1016/S0140-6736(12)60404-8, 10.1016/S0140-6736(16)31357-5]
[7]   Estimation of ten-year risk of fatal cardiovascular disease in Europe:: the SCORE project [J].
Conroy, RM ;
Pyörälä, K ;
Fitzgerald, AP ;
Sans, S ;
Menotti, A ;
De Backer, G ;
De Bacquer, D ;
Ducimetière, P ;
Jousilahti, P ;
Keil, U ;
Njolstad, I ;
Oganov, RG ;
Thomsen, T ;
Tunstall-Pedoe, H ;
Tverdal, A ;
Wedel, H ;
Whincup, P ;
Wilhelmsen, L ;
Graham, IM .
EUROPEAN HEART JOURNAL, 2003, 24 (11) :987-1003
[8]   Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study [J].
Currie, Craig J. ;
Peters, John R. ;
Tynan, Aodan ;
Evans, Marc ;
Heine, Robert J. ;
Bracco, Oswaldo L. ;
Zagar, Tony ;
Poole, Chris D. .
LANCET, 2010, 375 (9713) :481-489
[9]   General cardiovascular risk profile for use in primary care - The Framingham Heart Study [J].
D'Agostino, Ralph B. ;
Vasan, Ramachandran S. ;
Pencina, Michael J. ;
Wolf, Philip A. ;
Cobain, Mark ;
Massaro, Joseph M. ;
Kannel, William B. .
CIRCULATION, 2008, 117 (06) :743-753
[10]   Diabetes, Glycated Hemoglobin, and the Risk of Myocardial Infarction in Women and Men: A Prospective Cohort Study of the UK Biobank [J].
de Jong, Marit ;
Woodward, Mark ;
Peters, Sanne A. E. .
DIABETES CARE, 2020, 43 (09) :2050-2059